TGFB1 and cancer: Both of these agents can abrogate the enhancement of u-PA levels induced by TGF-β1 and also inhibit the TGF-β1-induced synthesis of fibronectin [12], inferring that some natural products have the potential to be effective in the treatment of cancer.